Emerging economies and diabetes and cardiovascular disease

Diabetes Technology and Therapeutics

Volumn 14, Issue SUPPL. 1, 2012, Pages

  Pradeepa, Rajendra ^a   Prabhakaran, Dorairaj ^b   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CHINA; CULTURAL FACTOR; DEMOGRAPHY; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ECONOMIC DEVELOPMENT; ENVIRONMENTAL FACTOR; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FINANCING; HEREDITY; HUMAN; INDIA; INDUSTRIALIZATION; INSULIN DEPENDENT DIABETES MELLITUS; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LOWEST INCOME GROUP; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL HEALTH; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; RISK FACTOR; RUSSIAN FEDERATION; SMOKING CESSATION; SOUTH AFRICA; URBANIZATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; EPIDEMICS; FEMALE; HEALTH PRIORITIES; HUMANS; LIFE EXPECTANCY; LIFE STYLE; MALE; MIDDLE AGED; MORBIDITY; POPULATION DYNAMICS; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH; RISK FACTORS; URBANIZATION;

EID: 84861910095     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0065     Document Type: Article

References (69)

1. Wagner JH, Brath H: A global view on the development of non communicable diseases. Prev Med 2011 Dec 8 [Epub ahead of print]. DOI: 10.1016/j.ypmed.2011. 11.012.
2. Alwan A, Maclean DR, Riley LM, d'Espaignet ET, Mathers CD, Stevens GA, Bettcher D: Monitoring and surveillance of chronic noncommunicable diseases: Progress and capacity in high-burden countries. Lancet 2010;376:1861-1868.
3. Global Status Report on Non Communicable Diseases. Geneva: World Health Organization, 2010.
4. Unwin N, Whiting D, Guariguata L, Ghyoot G, Gan D, eds. Diabetes Atlas, 5th ed. Brussels: International Diabetes Federation, 2011:11-74.
5. Mbanya JC: The challenges of diabetes in the developing world. In: Pickup JC, Williams G, eds. Textbook of Diabetes, 3rd edition. Oxford, UK: Blackwell Publishing Co., 2003:8.1-8.14.
6. Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H: Gistribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: A cross-sectional population-based survey in rural Uganda. Int J Epidemiol 2011;40:160-171.
7. Christensen DL, Friis H, Mwaniki DL, Kilonzo B, Tetens I, Boit MK, Omondi B, Kaduka L, Borch-Johnsen K: Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 2009;84:303-310.
8. Nigatu T: Epidemiology, complications and management of diabetes in Ethiopia: A systematic review. J Diabetes 2011 Dec 23 [Epub ahead of print]. DOI: 10.1111/j.1753-0407. 2011.00181.x.
9. Hussain A, Rahim MA, Azad Khan AK, Ali SM, Vaaler S: Type 2 diabetes in rural and urban population: Giverse prevalence and associated risk factors in Bangladesh. Diabet Med 2005;22:931-936.
10. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka-Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med 2008;25:1062-1069.
11. National Basic Health Research 2007, Official Report [translated from RISKESDAS 2007, Sidartawan Soegondo]. Jakarta: Ministry of Health, Republic of Indonesia, 2008.
12. Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, Isa MR, Zanariah H, Fatanah I, Ahmad Faudzi Y: Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia 2010;65:180-186.
13. Aekplakorn W, Chariyalertsak S, Kessomboon P, Sangthong R, Inthawong R, Putwatana P, Taneepanichskul S; Thai National Health Examination Survey IV Study Group: Prevalence and management of diabetes and metabolic risk factors in Thai adults: The Thai National Health Examination Survey IV, 2009. Diabetes Care 2011;34:1980-1985.
14. Basit A, Danish Alvi SF, Fawwad A, Ahmed K, Yakoob Ahmedani M, Hakeem R: Temporal changes in the prevalence of diabetes, impaired fasting glucose and its associated risk factors in the rural area of Baluchistan. Diabetes Res Clin Pract 2011;94:456-462.
15. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362: 1090-1101.
16. Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, Rema M, Mohan V: The need for obtaining accurate nationwide estimates of diabetes prevalence in India-rationale for a national study on diabetes. Indian J Med Res 2011;133:369-380.
17. Ahuja MMS: Epidemiology studies on diabetes mellitus in India. In: Ahuja MMS, ed. Epidemiology of Diabetes in Developing Countries. New Delhi: Interprint, 1979:29-38.
18. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD; Diabetes Epidemiology Study Group in India (DESI): High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-1101.
19. Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, Sosale A, Munichoodappa C, Seshiah V, Singh SK, Jamal A, Sai K, Sadasivrao Y, Murthy SS, Hazra DK, Jain S, Mukherjee S, Bandyopadhay S, Sinha NK, Mishra R, Dora M, Jena B, Patra P, Goenka K: Giabetes India. The burden of diabetes and impaired fasting glucose in India using the ADA1997 criteria: Prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66:293-300.
20. Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, Anand K, Desai NG, Joshi PP, Mahanta J, Thankappan KR, Shah B: Urban rural differences in prevalence of self reported diabetes in India-The WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract 2008;80:159-168.
21. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Nath LM, Das AK, Madhu SV, Rao PV, Shukla DK, Kaur T, Ali MK, Mohan V: The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: Methodological details. J Diabetes Sci Technol 2011;5:906-914.
22. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla DK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V; ICMR-INDIAB Collaborative Study Group: Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027.
23. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294.
24. Mohan V, Pradeepa R: Epidemic of Type 2 diabetes in developing nations. Curr Med Lit 2004;21:69-76.
25. Abu Sayeed M, Ali L, Hussain MZ, Rumi MA, Banu A, Azad Khan AK: Effect of socioeconomic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh. Diabetes Care 1997;20:551-555.
26. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R: Intra-urban differences in the prevalence of the metabolic syndrome in southern India-The Chennai Urban Population Study (CUPS No. 4). Diabet Med 2001;18:280-287.
27. Lissock CN, Sobngwi E, Ngassam E, Ngoa Etoundi LS: Rural and urban differences in metabolic profiles in a Cameroonian population. Pan Afr Med J 2011;10:1.
28. Allender S, Wickramasinghe K, Goldacre M, Matthews D, Katulanda P: Quantifying urbanization as a risk factor for noncommunicable disease. J Urban Health 2011;88:906-918.
29. Deepa M, Anjana RM, Manjula D, Narayan KM, Mohan V: Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study. J Diabetes Sci Technol 2011;5:918-927.
30. Ali MK, Weber MB, Narayan KM: The global burden of diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, eds. Textbook of Diabetes, 4th ed. Hoboken, NJ: Wiley-Blackwell, 2010:69-84.
31. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, Badgandi M, Iyengar SS, Viswanathan V, Sivakadaksham N, Chattopadhyaya PS, Biswas AD, Jindal S, Khan IA, Sethi BK, Rao VD, Dalal JJ; Site Investigators: Prevalence of diagnosed and undiagnosed diabetes and hypertension in India-results from the Screening India's Twin Epidemic (SITE) Study. Diabetes Technol Ther 2012;14:8-15.
32. Ma RCW, Tong PCY: Epidemiology of type 2 diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, eds. Textbook of Diabetes, 4th ed. Hoboken, NJ: Wiley-Blackwell, 2010:45-68.
33. Cusick M, Meleth AD, Agrón E, Fisher MR, Reed GF, Knatterud GL, Barton FB, Davis MD, Ferris FL 3rd, Chew EY; Early Treatment Diabetic Retinopathy Study Research Group: Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: Early Treatment Diabetic Retinopathy Study report no. 27. Diabetes Care 2005;28:617-625.
34. Mohan V, Shanthirani CS, Deepa M, Deepa R, Unnikrishnan RI, Datta M: Mortality rates due to diabetes in a selected urban south Indian population-The Chennai Urban Population Study [CUPS-16]. J Assoc Physicians India 2006; 54:113-117.
35. Zargar AH, Wani AI, Masoodi SR, Bashir MI, Laway BA, Gupta VK, Wani FA: Causes of mortality in diabetes mellitus: Gata from a tertiary teaching hospital in India. Postgrad Med J 2009;85:227-232.
36. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study-I. Invest Ophthalmol Vis Sci 2005;46:2328-2333.
37. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-45). Diabetes Care 2007;30:2019-2024.
38. Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V: Prevalence and risk factors of peripheral vascular disease in a selected South Indian population. The Chennai Urban Population Study (CUPS). Diabetes Care 2000;23:1295-1300.
39. Mohan V, Deepa R, Shanthirani CS, Premalatha G: Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India-The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001;38:682-687.
40. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V: Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med 2008;25:407-412.
41. Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, Mbanya JC, Ohwovoriole AE: Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa study. Diabetes Res Clin Pract 2012;95:30-36.
42. World Health Organization: Causes of Death 2008. www.who.int/gho/ mortality-burden-disease/causes-death-2008/en/ (accessed February 13, 2012).
43. World Health Organization: The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
44. Levenson JW, Skerrett PJ, Gaziano JM: Reducing the global burden of cardiovascular disease: The role of risk factors. Prev Cardiol 2002;5:188-199.
45. Murray CJL, Lopez AD: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
46. Saxena A: Strategies for the improvement of cardiac care services in developing countries: What does the future hold? Future Cardiol 2012;8:29-38.
47. Leeder S, Raymond S, Greenberg H, Liu H, Esson K: A Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York: Trustees of Columbia, 2004.
48. World Health Organization: Cardiovascular Diseases. 2009. www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed February 13, 2012).
49. Indrayan A: Forecasting Vascular Disease Cases and Associated Mortality in India. National Commission on Macroeconomics and Health Background Papers-Burden of Disease in India. New Delhi: National Commission on Macroeconomics and Health, 2005:197-215.
50. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Final Report of the Commission on Social Determinants of Health. Geneva: World Health Organization, 2008.
51. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S: Novel therapeutic concepts: The epidemic of cardiovascular disease in the developing world: Global implications. Eur Heart J 2010;31: 642-648.
52. Kinra S, Andersen E, Ben-Shlomo Y, Bowen L, Lyngdoh T, Prabhakaran D, Reddy KS, Ramakrishnan L, Bharathi A, Vaz M, Kurpad A, Smith GD, Ebrahim S; Indian Migration Study Group: Association between urban life-years and cardiometabolic risk: The Indian migration study. Am J Epidemiol 2011;174:154-164.
53. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali H, Keltai M, Diaz R, Rangarajan S, Yusuf S: Risk factors for myocardial infarction in women and men: Insights from the INTERHEART study. Eur Heart J 2008; 29:932-940.
54. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S: Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007; 297:286-294.
55. Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S: Potentially modifiable risk factors associated with myocardial infarction in China: The INTERHEART China Study. Heart 2009;95:1857-1864.
56. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-952.
57. Critchley J, Liu J, Zhao D, Wei W, Capewel S: Explaining the increase in coronary heart disease mortality in Beijing between 1984-1999. Circulation 2004;110:1236-1244.
58. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, Yusuf S: Gietary patterns and the risk of acute myocardial infarction in 52 countries: Results of the INTERHEART study. Circulation 2008;118:1929-1937.
59. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S: Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study. Lancet 2006; 368:647-658.
60. Rosengren A, Subramanian SV, Islam S, Chow CK, Avezum A, Kazmi K, Sliwa K, Zubaid M, Rangarajan S, Yusuf S; INTERHEART Investigators: Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study. Heart 2009;95: 2014-2022.
61. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization, 2009.
62. Mendis S, Puska P, Norrving B, eds. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization, Geneva, 2011. http://whqlibdoc.who.int/publications/2011/9789241564373-eng.pdf (accessed February 22, 2012).
63. World Health Organization, World Economic Forum: From Burden to Best Buys'': Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. www.who.int/nmh/publications/best-buys-summary.pdf (accessed February 22, 2012).
64. Ustun TB, Chatterji S, Mechbal A, Murray CJL, WHS Collaborating Groups: The World Health Surveys in Health Systems Performance Assessment: Gebates, Methods and Empiricism. Geneva: World Health Organization, 2003.
65. Kapur A. Economic analysis of diabetes care. Indian J Med Res 2007;125:473-482.
66. Fuster V, Kelly BB, eds.; Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; Institute of Medicine: Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: National Academies Press, 2010.
67. Engelgau MM, Engelgau MM, El-Saharty S, Kudesia P, Ranjan V, Rosenhouse S, Okamoto K: Capitalizing on the Demographic Transition: Tackling Noncommunicable Diseases in South Asia. Washington, DC: World Bank, 2011.
68. Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay VS, Goenka S, Calcagno JI, Caporale JE, Niu S, Li Y, Liu J, Thankappan KR, Daivadanam M, Van Esch J, Murphy A, Moran AE, Gaziano TA, Suhrcke M, Reddy KS, Leeder S, Prabhakaran D: Crosssectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One 2011;6:e20821.
69. Mayosi B, Flisher A, Lalloo U, Sitas F, Tollman S, Bradshaw D: The burden of non-communicable diseases in South Africa. Lancet 2009;374:934-947.